Iambic Therapeutics, Inc. [IAM] - IPO

Iambic Therapeutics, Inc. priced its IPO at $16.00 per share, offering 9,375,000 shares for total gross proceeds of $150 million, with existing investors ARK Investment Management LLC and Duquesne Family Office LLC indicating interest to purchase up to $60 million in shares.

View source filing ↗